NCT07146022: Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- State
- Under way
- Phase
- Phase 3
- People
- 552 planned
- Started
- 25 Jul 2025
- Primary completion
- Jun 2027
- Arms
- VDPHL01 BID
- Results
- None posted
- 25 Jul 2025: Trial started
- 28 Aug 2025: Trial registered